nanotech investing Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process
nanotech investing Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process
nanotech investing Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process
nanotech investing Universal Ibogaine advises further on application for Management Cease Trade Order
Quebec Innovative Materials Corp. Announces U.S. Affiliate Orvian Receives Minnesota DNR Registration for Exploratory Boring